Remove Acquisitions Remove Medical Remove Negotiation
article thumbnail

Cooley’s 2024 Life Sciences M&A Year in Review: M&A Slims Down in 2024, but Will Appetites Grow in 2025?

Cooley M&A

billion acquisition of Alpine Immune; by contrast, there were eight US biotech acquisitions exceeding $5 billion in 2023. 2024 saw companies focusing on internal research and development, innovative partnerships, and targeted bolt-on asset acquisitions to bolster their pipelines. from 2023. [1]

M&A 64
article thumbnail

Diamonds or Burst Pipes? What Current Pressures Mean for the Future of K-12

Tyton Partners

As one superintendent puts it, “The cost of everything keeps going up – building, transportation, medical costs. Take BetterLesson: through its recent acquisition of Abl , the company has reimagined its historical focus on teacher coaching to district-level talent management and program transformation.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

2025 Dental Transactions Update

Focus Investment Banking

This creates an incentive to grow before a sale, as increasing the DSO’s EBITDA through acquisition will likely increase its transaction value. We have observed highly competitive offers in dental and other medical specialties when buyers are nearing their own sales. Second, some of the younger DSOs are in an initial growth phase.

article thumbnail

Trends and Tips for Navigating Life Sciences M&A in 2024

JD Supra: Mergers

Dealmaking in the life sciences sector comes with characteristics not typically seen in more traditional mergers and acquisitions (M&A). Deals often involve negotiating around complexities associated with both the unique nature of assets of life sciences companies and the unique industry ecosystem that brings these assets to life.

M&A 161
article thumbnail

From $3M to $11M in 3 Years: Nikolas Hulewsky's Entrepreneurial Secrets Revealed!

How2Exit

- Watch Here About the Guest(s): Nicholas Hulewsky is a seasoned entrepreneur and investor with a rich background in healthcare and mergers and acquisitions. The conversation touches on topics like market research, off-market acquisitions, building relationships, and identifying opportunities with great potential.

article thumbnail

How Private Equity uses ‘Roll-up’ Strategies to Drive Investment Returns

OfficeHours

One of these “new” strategies that has grown in popularity over the past decade is the concept of “roll-ups” (also sometimes called “platform acquisition strategies”). This begs an important question: why do roll-ups receive a higher value than smaller acquisition targets? and thus receive volume discounts with better pricing.

article thumbnail

Cultural Considerations in International Mergers and Acquisitions

Lake Country Advisors

International mergers and acquisitions (M&A) offer the potential for rapid market expansion, access to cutting-edge technologies, and significant cost savings. Knowing whether to approach a single decision-maker or engage with a group can be essential for successful negotiations.